Hydroxypyridine cgrp receptor antagonists
    5.
    发明申请
    Hydroxypyridine cgrp receptor antagonists 审中-公开
    羟基吡啶cgrp受体拮抗剂

    公开(公告)号:US20060173046A1

    公开(公告)日:2006-08-03

    申请号:US10564706

    申请日:2004-07-09

    CPC分类号: C07D417/04 C07D471/04

    摘要: The present invention is directed to compounds of Formula I: I (where variables R1, R2, R3 and R4 are as defined herein) useful as antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to the use of such compounds as ligands of AM receptors for the treatment or prevention of diseases in which AM is involved, such as cancer. The invention is further directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP and/or AM are involved.

    摘要翻译: 本发明涉及式I化合物:其中变量R 1,R 2,R 3和R 4 可用作CGRP受体的拮抗剂,可用于治疗或预防涉及CGRP的疾病,例如头痛,偏头痛和丛集性头痛。 本发明还涉及这样的化合物作为AM受体的配体用于治疗或预防涉及AM的疾病如癌症的用途。 本发明进一步涉及包含这些化合物的药物组合物以及这些化合物和组合物在预防或治疗涉及CGRP和/或AM的疾病中的用途。